181 related articles for article (PubMed ID: 38634790)
1. Blood-Based Multiomics-Guided Detection of a Precancerous Pancreatic Tumor.
Anwar MA; Keshteli AH; Yang H; Wang W; Li X; Messier HM; Cullis PR; Borchers CH; Fraser R; Wishart DS
OMICS; 2024 Apr; 28(4):182-192. PubMed ID: 38634790
[TBL] [Abstract][Full Text] [Related]
2. Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort.
O'Neill RS; Emmanuel S; Williams D; Stoita A
World J Gastroenterol; 2020 Apr; 26(14):1660-1673. PubMed ID: 32327914
[TBL] [Abstract][Full Text] [Related]
3. Multiomics Data Triangulation for Asthma Candidate Biomarkers and Precision Medicine.
Pecak M; Korošec P; Kunej T
OMICS; 2018 Jun; 22(6):392-409. PubMed ID: 29927718
[TBL] [Abstract][Full Text] [Related]
4. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer.
Hanna-Sawires RG; Schiphuis JH; Wuhrer M; Vasen HFA; van Leerdam ME; Bonsing BA; Mesker WE; van der Burgt YEM; Tollenaar RAEM
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800786
[TBL] [Abstract][Full Text] [Related]
5. Early detection of pancreatic cancer using DNA-based molecular approaches.
Singhi AD; Wood LD
Nat Rev Gastroenterol Hepatol; 2021 Jul; 18(7):457-468. PubMed ID: 34099908
[TBL] [Abstract][Full Text] [Related]
6. A review of lifestyle, metabolic risk factors, and blood-based biomarkers for early diagnosis of pancreatic ductal adenocarcinoma.
Pang Y; Holmes MV; Chen Z; Kartsonaki C
J Gastroenterol Hepatol; 2019 Feb; 34(2):330-345. PubMed ID: 30550622
[TBL] [Abstract][Full Text] [Related]
7. Updates of liquid biopsy in oral cancer and multiomics analysis.
Zhang X; Li B
Oral Dis; 2023 Jan; 29(1):51-61. PubMed ID: 34716963
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.
McGuigan A; Kelly P; Turkington RC; Jones C; Coleman HG; McCain RS
World J Gastroenterol; 2018 Nov; 24(43):4846-4861. PubMed ID: 30487695
[TBL] [Abstract][Full Text] [Related]
9. Integration of Omics and Phenotypic Data for Precision Medicine.
Zhao J; Feng Q; Wei WQ
Methods Mol Biol; 2022; 2486():19-35. PubMed ID: 35437716
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer.
Takai E; Yachida S
World J Gastroenterol; 2016 Oct; 22(38):8480-8488. PubMed ID: 27784960
[TBL] [Abstract][Full Text] [Related]
11. Early detection markers in Pancreas Cancer.
Farrell JJ; van Rijnsoever M; Elsaleh H
Cancer Biomark; 2005; 1(2-3):157-75. PubMed ID: 17192037
[TBL] [Abstract][Full Text] [Related]
12. Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine.
Jose A; Kulkarni P; Thilakan J; Munisamy M; Malhotra AG; Singh J; Kumar A; Rangnekar VM; Arya N; Rao M
Mol Cancer; 2024 Mar; 23(1):50. PubMed ID: 38461268
[TBL] [Abstract][Full Text] [Related]
13. Multiomics, artificial intelligence, and precision medicine in perinatology.
Pammi M; Aghaeepour N; Neu J
Pediatr Res; 2023 Jan; 93(2):308-315. PubMed ID: 35804156
[TBL] [Abstract][Full Text] [Related]
14. Highly Accurate Identification of Cystic Precursor Lesions of Pancreatic Cancer Through Targeted Mass Spectrometry: A Phase IIc Diagnostic Study.
Jabbar KS; Arike L; Verbeke CS; Sadik R; Hansson GC
J Clin Oncol; 2018 Feb; 36(4):367-375. PubMed ID: 29166170
[TBL] [Abstract][Full Text] [Related]
15. Transforming Cancer Prevention through Precision Medicine and Immune-oncology.
Kensler TW; Spira A; Garber JE; Szabo E; Lee JJ; Dong Z; Dannenberg AJ; Hait WN; Blackburn E; Davidson NE; Foti M; Lippman SM
Cancer Prev Res (Phila); 2016 Jan; 9(1):2-10. PubMed ID: 26744449
[TBL] [Abstract][Full Text] [Related]
16. Multiomics Approach to Acromegaly: Unveiling Translational Insights for Precision Medicine.
Kim K; Ku CR; Lee EJ
Endocrinol Metab (Seoul); 2023 Oct; 38(5):463-471. PubMed ID: 37828709
[TBL] [Abstract][Full Text] [Related]
17. Strategies for early detection of resectable pancreatic cancer.
Okano K; Suzuki Y
World J Gastroenterol; 2014 Aug; 20(32):11230-40. PubMed ID: 25170207
[TBL] [Abstract][Full Text] [Related]
18. Screening for pancreatic cancer has the potential to save lives, but is it practical?
Mazer BL; Lee JW; Roberts NJ; Chu LC; Lennon AM; Klein AP; Eshleman JR; Fishman EK; Canto MI; Goggins MG; Hruban RH
Expert Rev Gastroenterol Hepatol; 2023; 17(6):555-574. PubMed ID: 37212770
[TBL] [Abstract][Full Text] [Related]
19. Towards a Personalized Approach in Pancreatic Cancer Diagnostics Through Plasma Amino Acid Analysis.
Tumas J; Baskirova I; Petrenas T; Norkuniene J; Strupas K; Sileikis A
Anticancer Res; 2019 Apr; 39(4):2035-2042. PubMed ID: 30952747
[TBL] [Abstract][Full Text] [Related]
20. Imaging modalities for characterising focal pancreatic lesions.
Best LM; Rawji V; Pereira SP; Davidson BR; Gurusamy KS
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010213. PubMed ID: 28415140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]